Impact Of Bifunctional Chelators On Biological Properties Of In-111-Labeled Cyclic Peptide Rgd Dimers
Jiyun Shi,Young-Seung Kim,Sudipta Chakraborty,Yang Zhou,Fan Wang,Shuang Liu
DOI: https://doi.org/10.1007/s00726-009-0439-0
IF: 3.7891
2011-01-01
Amino Acids
Abstract:The present study describes the synthesis and biological evaluation of In-111(DOTA-3P-RGD(2)) (DOTA = 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraacetic acid; 3P-RGD(2) = PEG(4)-E[PEG(4)-c(RGDfK)](2); PEG(4) = 15-amino-4,7,10,13-tetraoxapentadecanoic acid), In-111(DTPA-3P-RGD(2)) (DTPA = diethylenetriaminepentaacetic acid) and In-111(DTPA-Bn-3P-RGD(2)) (DTPA-Bn = 2-(p-thioureidobenzyl)-diethylenetriaminepentaacetic acid) as potential radiotracers for imaging tumor integrin alpha(v)beta(3) expression in athymic nude mice bearing U87MG glioma xenografts. The aim of the study is to assess the impact of the bifunctional chelator (BFC) (DOTA vs. DTPA or DTPA-Bn) on the biodistribution characteristics of the In-111-labeled 3P-RGD(2). IC50 values of DOTA-3P-RGD(2), DTPA-3P-RGD(2) and DTPA-Bn-3P-RGD(2) were determined to be 1.3 +/- A 0.2, 1.4 +/- A 0.3, 1.3 +/- A 0.3 nM, respectively, against I-125-c(RGDyK) bound to U87MG human glioma cells. Radiotracers were prepared by reacting (InCl3)-In-111 with the RGD peptide conjugates in NH4OAc buffer (100 mM, pH 5.5). For DOTA-3P-RGD(2), successful radiolabeling could be completed by heating the reaction mixture at 100A degrees C for 15-20 min. For DTPA-3P-RGD(2) and DTPA-Bn-3P-RGD(2), the radiolabeling was almost instantaneous at room temperature. The specific activity was similar to 50 mCi/mg (or similar to 100 mCi/mu mol) for In-111(DOTA-3P-RGD(2)) and similar to 200 mCi/mg (or similar to 400 mCi/mu mol) for In-111(DTPA-3P-RGD(2)). The results from biodistribution studies showed that all the three radiotracers have high tumor uptake and excellent tumor-to-background (T/B) ratios up to 4-h postinjection. After that time point, both In-111(DTPA-3P-RGD(2)) and In-111(DTPA-Bn-3P-RGD(2)) showed a much faster tumor washout and poorer T/B ratios than In-111(DOTA-3P-RGD(2)). The tumor uptake of In-111(DOTA-3P-RGD(2)) is integrin alpha(v)beta(3)- and RGD-specific. In-111(DOTA-3P-RGD(2)) is metabolically stable while only similar to 25% of In-111(DTPA-Bn-3P-RGD(2)) remains intact in the feces during 2-h period. On the basis of results from this study, it was concluded that In-111(DTPA-3P-RGD(2)) can be an effective integrin alpha(v)beta(3)-targeted radiotracer if the high-specific activity is required. However, DOTA remains to be the BFC of choice for the development of therapeutic lanthanide radiotracers.